Health and Fitness Health and Fitness
Mon, June 25, 2012
[ Mon, Jun 25th 2012 ] - Market Wire
Myths or Factsa" Campaign
Sun, June 24, 2012
Sat, June 23, 2012
Fri, June 22, 2012
Thu, June 21, 2012
Wed, June 20, 2012
Tue, June 19, 2012
Mon, June 18, 2012
Sun, June 17, 2012
Sat, June 16, 2012
Fri, June 15, 2012
Thu, June 14, 2012
Wed, June 13, 2012
Tue, June 12, 2012
Mon, June 11, 2012
Sat, June 9, 2012
Fri, June 8, 2012
Thu, June 7, 2012

Equities Lead Investor Sentiment - Research Report on Abbott Laboratories and GlaxoSmithKline plc (ADR)


//health-fitness.news-articles.net/content/2012/ .. tt-laboratories-and-glaxosmithkline-plc-adr.html
Published in Health and Fitness on Thursday, June 14th 2012 at 6:15 GMT by Market Wire   Print publication without navigation


June 14, 2012 09:00 ET

Equities Lead Investor Sentiment - Research Report on Abbott Laboratories and GlaxoSmithKline plc (ADR)

HONG KONG--(Marketwire - Jun 14, 2012) - Today, [ www.EquityLeader.com ] introduced research coverage of Abbott Laboratories (NYSE: [ ABT ]) and GlaxoSmithKline plc (ADR) (NYSE: [ GSK ]). Full research reports are available to readers at: [ www.EquityLeader.com/index.php?sm1=ABT&sm2=GSK ].

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Abbott Laboratories for its current position within the healthcare industry. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. A copy of this report detailing Abbott Laboratories (NYSE: [ ABT ]) is available at: [ www.EquityLeader.com/index.php?sm1=ABT ].

Equity Leader is also taking note of GlaxoSmithKline plc (ADR) for its changing role within the healthcare industry. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. To download free research on GlaxoSmithKline plc (ADR) (NYSE: [ GSK ]) investors may visit: [ www.EquityLeader.com/index.php?sm2=GSK ].

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.



Publication Contributing Sources